Article info

PDF

The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder

Authors

  1. Correspondence to Dr Kim Boesen, Nordic Cochrane Centre, Rigshospitalet, Dept. 7811, Blegdamsvej 9, Copenhagen DK-2100, Denmark; kb{at}cochrane.dk

Citation

Boesen K, Saiz LC, Erviti J, et al
The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder

Publication history

  • Accepted June 26, 2017
  • First published July 13, 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.